FINANCIERE MARJOS (FINM.PA) Fundamental Analysis & Valuation

EPA:FINM • FR0000060824

Current stock price

0.9 EUR
+0.02 (+2.27%)
Last:

This FINM.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. FINM.PA Profitability Analysis

1.1 Basic Checks

  • In the past year FINM has reported negative net income.
  • In the past year FINM has reported a negative cash flow from operations.
  • FINM had negative earnings in 4 of the past 5 years.
  • FINM had a negative operating cash flow in each of the past 5 years.
FINM.PA Yearly Net Income VS EBIT VS OCF VS FCFFINM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200K -400K -600K

1.2 Ratios

  • Looking at the Return On Assets, with a value of -312.50%, FINM is doing worse than 73.91% of the companies in the same industry.
Industry RankSector Rank
ROA -312.5%
ROE N/A
ROIC N/A
ROA(3y)-564.48%
ROA(5y)-399.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FINM.PA Yearly ROA, ROE, ROICFINM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • FINM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FINM.PA Yearly Profit, Operating, Gross MarginsFINM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

0

2. FINM.PA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, FINM has about the same amount of shares outstanding.
  • FINM has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, FINM has a worse debt to assets ratio.
FINM.PA Yearly Shares OutstandingFINM.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
FINM.PA Yearly Total Debt VS Total AssetsFINM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K

2.2 Solvency

  • Based on the Altman-Z score of -57.21, we must say that FINM is in the distress zone and has some risk of bankruptcy.
  • FINM has a worse Altman-Z score (-57.21) than 66.09% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -57.21
ROIC/WACCN/A
WACCN/A
FINM.PA Yearly LT Debt VS Equity VS FCFFINM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K -1M

2.3 Liquidity

  • A Current Ratio of 0.11 indicates that FINM may have some problems paying its short term obligations.
  • FINM has a Current ratio of 0.11. This is in the lower half of the industry: FINM underperforms 65.22% of its industry peers.
  • A Quick Ratio of 0.11 indicates that FINM may have some problems paying its short term obligations.
  • FINM's Quick ratio of 0.11 is on the low side compared to the rest of the industry. FINM is outperformed by 65.22% of its industry peers.
Industry RankSector Rank
Current Ratio 0.11
Quick Ratio 0.11
FINM.PA Yearly Current Assets VS Current LiabilitesFINM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M

1

3. FINM.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 100.00% over the past year.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. FINM.PA Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
FINM.PA Price Earnings VS Forward Price EarningsFINM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FINM.PA Per share dataFINM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.01 -0.02 -0.03 -0.04 -0.05

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. FINM.PA Dividend Analysis

5.1 Amount

  • FINM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

FINM.PA Fundamentals: All Metrics, Ratios and Statistics

FINANCIERE MARJOS

EPA:FINM (4/29/2026, 7:00:00 PM)

0.9

+0.02 (+2.27%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Industry Strength58.11
Industry Growth60
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners62%
Ins Owner ChangeN/A
Market Cap17.97M
Revenue(TTM)N/A
Net Income(TTM)-150.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.06
TBVpS-0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -312.5%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-564.48%
ROA(5y)-399.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.11
Quick Ratio 0.11
Altman-Z -57.21
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

FINANCIERE MARJOS / FINM.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FINANCIERE MARJOS (FINM.PA) stock?

ChartMill assigns a fundamental rating of 0 / 10 to FINM.PA.


Can you provide the valuation status for FINANCIERE MARJOS?

ChartMill assigns a valuation rating of 0 / 10 to FINANCIERE MARJOS (FINM.PA). This can be considered as Overvalued.


What is the profitability of FINM stock?

FINANCIERE MARJOS (FINM.PA) has a profitability rating of 0 / 10.


What is the financial health of FINANCIERE MARJOS (FINM.PA) stock?

The financial health rating of FINANCIERE MARJOS (FINM.PA) is 0 / 10.